Search
Menu
Home
HTB
2020
January
January 2020
Contents
Editorial
HTB 29 January 2020 online
Supplements
i-Base guide to HIV testing and sexual transmission (January 2020)
Antiretrovirals
FDA decision on long-acting cabotegravir/rilpivirine (Cabenuva, Vocabria) injections delayed due to scale-up manufacturing problems
Fostemsavir submitted to EMA for treating multidrug resistant HIV
Gilead announces licensing agreement for Rockefeller University bNAbs
PK and drug interactions
Updates to Liverpool University drug interactions website
Guidelines
US HIV Guidelines updated (December 2019)
BHIVA 2019 audit shows early access to ART but U=U and peer support both need to be improved
Vaccines and microbicides
FluAGE study supports BHIVA recommendations for HIV positive people to have annual flu shot
PDFs
29 January 2020 vol 21 no 1
HTB RSS
Early access
Closed clinics and limited ART in Zimbabwe, PEPFAR and UNAIDS news
4 May 2025
The RIO study: Q&A about controlling HIV with bNAbs
21 April 2025
Lenacapavir EAP in the UK closed to new referrals: NHS England and Gilead fail to agree a price after more than two years
20 April 2025
Viral failure on CAB/RPV-LA: overcoming drug resistance with second-generation INSTIs
13 April 2025
All early access reports
Current issues
May 2025
April 2025
March 2025
Back issues
Special report
Reduced dosing: a possible crisis response to ART stockouts and closed clinics
5 May 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate